| HPMC Raw-Material Control | Source, grade, viscosity, substitution level, and change-control procedures for hypromellose. | Approved raw-material supplier list, certificate of analysis, incoming-test records, and change-notification procedure. | Every lot should be traceable to raw-material batches, with documented specifications and controlled changes. | Reduces formulation variation, rejected lots, and unexpected qualification work. |
| Capsule Dimensions and Fit | Nominal size, body-cap fit, locking performance, wall thickness, and compatibility with filling equipment. | Approved drawings, dimensional inspection reports, machine compatibility trials, and retained samples. | Dimensions must remain within the agreed specification across production lots and filling-machine speeds. | Improves line efficiency and lowers risks of separation, leakage, or filling stoppages. |
| Mechanical Performance | Resistance to brittleness, deformation, cracking, denting, and cap-body separation during handling. | Internal mechanical test method, transport simulation, visual inspection criteria, and batch-release records. | Performance should be confirmed under the buyer’s actual temperature, humidity, and filling conditions. | Limits damage during manufacturing, warehousing, ocean freight, and final distribution. |
| Moisture and Storage Stability | Moisture content, water activity where applicable, packaging configuration, and recommended storage conditions. | Certificate of analysis, stability or transport studies, warehouse records, and packaging specifications. | The supplier should define temperature and relative-humidity limits and demonstrate protection through the planned logistics route. | Important for humid climates, long sea transit, and storage without climate-controlled facilities. |
| Microbiological Quality | Total aerobic microbial count, total yeast and mold count, and absence or control of specified microorganisms. | Validated methods aligned with applicable pharmacopoeial requirements, such as USP <61>, USP <62>, Ph. Eur. 2.6.12, and Ph. Eur. 2.6.13. | Acceptance limits must be agreed according to the finished-product application and applicable market requirements. | Prevents contamination-related holds, recalls, and regulatory delays. |
| Chemical and Physical Purity | Identity, residue on ignition or ash where applicable, elemental impurities, residual solvents, and other agreed limits. | Current specification, validated analytical methods, laboratory qualification records, and lot-specific test results. | Specifications should be matched to the destination market and the capsule’s pharmaceutical, nutraceutical, or food application. | Supports dossier approval and minimizes re-testing at the buyer’s site. |
| GMP and Quality Management | Deviation handling, CAPA, complaints, internal audits, training, document control, and batch release. | Quality manual, audit reports, CAPA examples, ISO 9001 certification, and documented GMP-aligned procedures. | The quality system should be independently audited and capable of providing complete lot traceability. | Improves consistency and shortens investigation time when a quality issue occurs. |
| Pharmaceutical Packaging Compliance | Controls for materials used as primary packaging components for medicinal products. | Where relevant, ISO 15378 certification or equivalent documented GMP controls for primary packaging materials. | Certification scope should cover the manufacturing site and the specific capsule product supplied. | Supports supplier qualification for regulated pharmaceutical programs. |
| Colorants and Printing Controls | Colorant identity, permitted-use status, migration risk, ink composition, print durability, and legibility. | Colorant or ink declarations, regulatory statements, migration assessments, artwork approval, and print inspection records. | All colors and printed materials should be approved for the intended market and product category. | Avoids relabeling, market-specific reformulation, and customs or regulatory objections. |
| Regulatory and Ethical Declarations | Animal-origin status, BSE/TSE status, allergen statement, GMO statement, irradiation status, and restricted-substance declarations. | Signed declarations, supporting raw-material documentation, and current certificates such as Halal or Kosher where required. | Declarations must be current, product-specific, and consistent with the destination-country requirements. | Enables access to pharmaceutical, nutraceutical, vegetarian, Halal, and Kosher markets. |
| Production Capacity and Scalability | Installed production lines, validated capacity, planned maintenance, capacity allocation, and surge-production capability. | Capacity statement, production plan, equipment list, maintenance schedule, and historical fulfillment data. | Capacity should cover forecast demand plus a documented contingency allowance without weakening quality controls. | Supports product launches, seasonal demand, and business continuity. |
| Lead-Time and Order Reliability | Standard production lead time, sample approval time, minimum order quantity, forecast requirements, and on-time delivery history. | Service-level agreement, purchase-order records, rolling forecast process, and documented escalation contacts. | Lead times should be confirmed in writing for standard, customized, printed, and urgent orders. | Helps buyers calculate safety stock and avoid production interruptions. |
| Packaging, Palletization, and Identification | Inner-bag protection, carton strength, pallet pattern, lot coding, barcode format, and packaging integrity. | Packaging specification, pallet diagram, label proof, packing-list format, and transport-test evidence. | Each shipping unit should be clearly identified and protected against moisture, compression, and mix-ups. | Reduces warehouse errors, transit damage, and receiving delays. |
| Traceability and Recall Readiness | Ability to trace finished capsules to raw materials, equipment, operators, inspection results, and shipment records. | Mock-recall results, lot-traceability procedure, retention-sample policy, and complaint-investigation records. | The manufacturer should demonstrate rapid identification of affected lots and distribution destinations. | Limits the scope and cost of a potential market withdrawal. |
| Geographic and Logistics Risk | Export experience, port access, customs documentation, alternate routes, freight options, and geopolitical exposure. | Business-continuity plan, logistics partner list, export documents, insurance coverage, and contingency-route assessment. | At least one practical contingency should exist for production disruption, port congestion, or transport interruption. | Improves resilience for international supply programs. |
| Total Cost of Ownership | Unit price together with freight, duties, inspection, rejected goods, inventory carrying cost, and qualification expense. | Landed-cost model, quality-performance history, payment terms, packaging details, and warranty or claim policy. | Select suppliers using verified landed cost and risk-adjusted performance rather than unit price alone. | Creates a more accurate comparison between domestic, regional, and overseas supply options. |